Validating Crohn's disease activity indices for use in assessing postoperative recurrence

Area of Science:

• Gastroenterology
• Clinical Medicine
• Inflammatory Bowel Disease Research

Background:

• The Crohn's Disease Activity Index (CDAI) is a standard measure in clinical trials, with scores below 150 indicating remission.
• Its utility in evaluating postoperative recurrence of Crohn's disease is not well-established.
• This study investigates the effectiveness of the CDAI in identifying symptomatic disease recurrence after ileocolic resection.

Purpose of the Study:

• To assess the value of the Crohn's Disease Activity Index (CDAI) in detecting symptomatic recurrence after ileocolic resection for Crohn's disease.
• To determine an optimal CDAI threshold for identifying postoperative recurrence.
• To compare CDAI performance against established endoscopic scoring systems.

Main Methods:

• Ninety-three patients underwent clinical and colonoscopic evaluation within 12 months of ileocolic resection.
• Recurrence was defined by symptoms and Rutgeerts endoscopic scores (≥ i2).
• Receiver operator curve (ROC) analysis was used to evaluate CDAI performance.

Main Results:

• 42% of patients showed recurrence within 12 months, with 22% symptomatic and 20% endoscopic only.
• Median CDAI was 198 for symptomatic recurrence versus 80 for asymptomatic patients.
• A CDAI of ≥ 148 demonstrated 70% sensitivity and 81% specificity for symptomatic recurrence.

Conclusions:

• The CDAI is a useful tool for assessing symptomatic recurrence in the postoperative setting, with a threshold of 150 being optimal.
• However, the CDAI alone may not be sufficient as a primary outcome measure in clinical trials.
• A combination of symptom assessment and endoscopic findings remains the gold standard for evaluating outcomes in postoperative Crohn's disease studies.